WO1997045746A3 - Prion protein binding proteins and uses thereof - Google Patents

Prion protein binding proteins and uses thereof Download PDF

Info

Publication number
WO1997045746A3
WO1997045746A3 PCT/IB1997/000827 IB9700827W WO9745746A3 WO 1997045746 A3 WO1997045746 A3 WO 1997045746A3 IB 9700827 W IB9700827 W IB 9700827W WO 9745746 A3 WO9745746 A3 WO 9745746A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding proteins
protein binding
prion protein
features
prpbps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB1997/000827
Other languages
French (fr)
Other versions
WO1997045746A2 (en
Inventor
Neil R Cashman
Vincent Dodelet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Priority to AU31863/97A priority Critical patent/AU3186397A/en
Priority to JP09541946A priority patent/JP2000512131A/en
Priority to EP97927319A priority patent/EP0920630B1/en
Priority to DE69714451T priority patent/DE69714451T2/en
Priority to AT97927319T priority patent/ATE221663T1/en
Priority to BR9709900-7A priority patent/BR9709900A/en
Publication of WO1997045746A2 publication Critical patent/WO1997045746A2/en
Publication of WO1997045746A3 publication Critical patent/WO1997045746A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

In general, the invention features prion protein binding proteins (PrPBPs) and diagnostic, therapeutic, and decontamination uses thereof. The invention also features fusion protein reagents for PrPBP isolation.
PCT/IB1997/000827 1996-05-29 1997-05-29 Prion protein binding proteins and uses thereof Ceased WO1997045746A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU31863/97A AU3186397A (en) 1996-05-29 1997-05-29 Prion protein binding proteins and uses thereof
JP09541946A JP2000512131A (en) 1996-05-29 1997-05-29 Prion protein binding protein and its use
EP97927319A EP0920630B1 (en) 1996-05-29 1997-05-29 Prion binding proteins and uses thereof
DE69714451T DE69714451T2 (en) 1996-05-29 1997-05-29 PRION-BINDING PROTEINS AND THEIR USE
AT97927319T ATE221663T1 (en) 1996-05-29 1997-05-29 PRION-BINDING PROTEINS AND THEIR USES
BR9709900-7A BR9709900A (en) 1996-05-29 1997-05-29 Protein binding proteins of prions and their uses.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1838096P 1996-05-29 1996-05-29
US60/018,380 1996-05-29

Publications (2)

Publication Number Publication Date
WO1997045746A2 WO1997045746A2 (en) 1997-12-04
WO1997045746A3 true WO1997045746A3 (en) 1998-04-09

Family

ID=21787631

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB1997/000827 Ceased WO1997045746A2 (en) 1996-05-29 1997-05-29 Prion protein binding proteins and uses thereof

Country Status (8)

Country Link
EP (1) EP0920630B1 (en)
JP (1) JP2000512131A (en)
AT (1) ATE221663T1 (en)
AU (1) AU3186397A (en)
BR (1) BR9709900A (en)
CA (1) CA2256312A1 (en)
DE (1) DE69714451T2 (en)
WO (1) WO1997045746A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197207B1 (en) * 1997-05-21 2001-03-06 Baxter International Inc. Method of reducing the possibility of transmission of spongiform encephalopathy diseases by blood products
AU7917598A (en) * 1997-05-30 1998-12-30 Stefan Weiss Pharmaceutical compositions comprising a soluble laminin receptor precursor or a compound which blocks the interactionof the laminin receptor precursor and prpsc or PrPc
DE19925073C2 (en) * 1999-06-01 2001-07-19 Stefan Weiss Nucleic acid molecules with specific recognition of native PrP · S ·· c ·, production and use
AU5602100A (en) 1999-06-09 2000-12-28 Arch Development Corporation Recombinant prion-like genes and proteins and materials and methods comprising same
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
WO2001000235A1 (en) * 1999-06-29 2001-01-04 Mcgill University Prion protein binding proteins and uses thereof
FR2801106B1 (en) * 1999-11-12 2007-10-05 Commissariat Energie Atomique METHOD FOR DIAGNOSING AN ATNC STRAIN-INDUCED TEST IN A BIOLOGICAL SAMPLE AND ITS USE IN THE DIFFERENTIAL DIAGNOSIS OF DIFFERENT ATNC STRAINS
IL148202A0 (en) * 2000-06-20 2002-09-12 Caprion Pharmaceuticals Inc Copolymers and methods of treating prion-related diseases
JP3515101B2 (en) 2000-06-27 2004-04-05 中外製薬株式会社 Method for evaluating binding activity between ligand and ligand binding protein
WO2003085086A2 (en) 2002-04-09 2003-10-16 The Scripps Research Institute Motif-grafted hybrid polypeptides and uses thereof
US20040072236A1 (en) * 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
ES2527408T3 (en) * 2002-12-03 2015-01-23 North Carolina State University Prion protein ligands and use procedures
US20050054003A1 (en) * 2003-09-10 2005-03-10 Stenland Christopher J. Prion clearance using particulate metal oxides
DE102007016324A1 (en) * 2007-04-04 2008-10-09 Priontype Gmbh & Co.Kg Method for the detection of pathologically altered prion protein (PrPSc)
WO2014025785A2 (en) * 2012-08-06 2014-02-13 Trustees Of Boston University Prion protein ligands as therapeutic agents for neurodegenerative disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016728A1 (en) * 1995-11-02 1997-05-09 The Regents Of The University Of California FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246766B (en) * 1990-11-12 1994-11-26 Medea Res Srl -

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016728A1 (en) * 1995-11-02 1997-05-09 The Regents Of The University Of California FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
CAUGHEY, BYRON ET AL: "Binding of the protease-sensitive form of prion protein PrP to sulfated glycosaminoglycan and Congo red", J. VIROL. (1994), 68(4), 2135-41 CODEN: JOVIAM;ISSN: 0022-538X, XP002056076 *
CHEMICAL ABSTRACTS, vol. 122, no. 5, 30 January 1995, Columbus, Ohio, US; abstract no. 49358, OESCH, BRUNO ET AL: "Interaction of the prion protein with cellular proteins" XP002056077 *
FLANAGAN JG ET AL: "The kit ligand: a cell surface molecule altered in steel mutant fibroblasts.", CELL, OCT 5 1990, 63 (1) P185-94, UNITED STATES, XP002056074 *
KURSCHNER, CORNELIA ET AL: "Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein", MOL. BRAIN RES. (1996), 37(1,2), 249-58 CODEN: MBREE4;ISSN: 0169-328X, XP002056075 *
OESCH, BRUNO ET AL: "Identification of cellular proteins binding to the scrapie prion protein", BIOCHEMISTRY (1990), 29(24), 5848-55 CODEN: BICHAW;ISSN: 0006-2960, XP002056073 *
OESCH, BRUNO: "Characterization of PrP binding proteins", PHILOS. TRANS. R. SOC. LONDON, SER. B (1994), 343(1306), 443-5 CODEN: PTRBAE;ISSN: 0080-4622, 1994, XP002041123 *
PRIOLA SA ET AL: "Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells.", INFECT AGENTS DIS, APR-JUN 1994, 3 (2-3) P54-8, UNITED STATES, XP002056072 *
PRION DIS. HUM. ANIM. (1992), 398-406. EDITOR(S): PRUSINER, STANLEY B. PUBLISHER: HORWOOD, LONDON, UK. CODEN: 60BWAD *
TELLING G C ET AL: "PRION PROPAGATION IN MICE EXPRESSING HUMAN AND CHIMERIC PRP TRANSGENES IMPLICATES THE INTERACTION OF CELLULAR PRP WITH ANOTHER PROTEIN", CELL, vol. 83, no. 1, 6 October 1995 (1995-10-06), pages 79 - 90, XP000674450 *
WEISS S ET AL: "OVEREXPRESSION OF ACTIVE SYRIAN GOLDEN HAMSTER PRION PROTEIN PRPC AS A GLUTATHIONE S-TRANSFERASE FUSION IN HETEROLOGOUS SYSTEMS", JOURNAL OF VIROLOGY, vol. 69, no. 8, August 1995 (1995-08-01), pages 4776 - 4783, XP000644456 *
YEHIELY, FRUMA ET AL: "Identification of candidate proteins binding to prion protein", NEUROBIOL. DIS. (1997), 3(4), 339-355 CODEN: NUDIEM;ISSN: 0969-9961, 1997, XP002041124 *

Also Published As

Publication number Publication date
JP2000512131A (en) 2000-09-19
DE69714451D1 (en) 2002-09-05
BR9709900A (en) 2000-01-25
EP0920630B1 (en) 2002-07-31
WO1997045746A2 (en) 1997-12-04
ATE221663T1 (en) 2002-08-15
DE69714451T2 (en) 2003-01-30
CA2256312A1 (en) 1997-12-04
AU3186397A (en) 1998-01-05
EP0920630A2 (en) 1999-06-09

Similar Documents

Publication Publication Date Title
ZA983496B (en) Methods for processing activated protein C.
AU2662795A (en) Cdk4 binding proteins
ZA9711239B (en) OB fusion protein compositions and methods.
AU1847497A (en) Protein expression system
WO2000020449A3 (en) MODIFIED TGF-β SUPERFAMILY PROTEINS
HUP0003533A3 (en) Interleukin-18 binding proteins, their preparation and use
AU3186397A (en) Prion protein binding proteins and uses thereof
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
ZA987908B (en) Functional protein concentrates and isolates.
WO1999020747A3 (en) HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS
WO2002012338A3 (en) Screening method
HK1038756A1 (en) Binding molecules for human factor viii and factor viii-like proteins
AU4606196A (en) Assay, receptor proteins and ligands
AU1620099A (en) Ubiquitin-like conjugating protein
AU1448697A (en) System for joining two parts along the facing planar surfaces thereof
AU2486900A (en) Rubredoxin fusion proteins, protein expression system and methods
AU5778400A (en) Prion protein binding proteins and uses thereof
WO1999035266A3 (en) Human urotensin ii
AU5137698A (en) Novel dna, novel protein, and novel antibody
EP0885959A3 (en) Human Wnt-5b protein
AU7368898A (en) Human translocation associated protein
EP1186662A3 (en) Prion binding proteins and uses thereof
EP0887416A3 (en) Human AFC1
AU4586497A (en) Calcium-integrin binding protein
ZA968185B (en) Protein.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN JP MX NZ RU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2256312

Country of ref document: CA

Ref country code: CA

Ref document number: 2256312

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997927319

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997927319

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1997927319

Country of ref document: EP